Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 4, 2006, Pages 697-705

  Kim Shapiro, Daniel B ^a   Schechter, Alan N ^b   Gladwin, Mark T ^c  

^a WAKE FOREST UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Hemoglobin; Nitric oxide; Nitrite; Red blood cell; Vasodilation

Indexed keywords

ANION; CYSTEINE; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANYLATE CYCLASE; HEMOGLOBIN; IRON; LIPID; NITRATED LIPID; NITRIC OXIDE; NITRITE; NITRITE ANION; NITRITE REDUCTASE; NITROSO DERIVATIVE; OXYHEMOGLOBIN; S NITROSOHEMOGLOBIN; S NITROSOTHIOL; UNCLASSIFIED DRUG;

BLOOD FLOW; BRAIN PROTECTION; CARDIOVASCULAR SYSTEM; CELL PROTECTION; CHEMICAL REACTION; CHEMICAL REACTION KINETICS; DIFFUSION; DIOXYGENATION; ENZYME ACTIVATION; ERYTHROCYTE; HEART PROTECTION; HEMOLYTIC ANEMIA; HUMAN; HYPOXIA; LAMINAR FLOW; MOLECULAR DYNAMICS; MOLECULAR STABILITY; NONHUMAN; OXYGENATION; PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REACTION ANALYSIS; REVIEW; SCAVENGING SYSTEM; THEORY; THERAPY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANEMIA, HEMOLYTIC; ANIMALS; BIOLOGICAL TRANSPORT; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOGLOBINS; HUMANS; NITRIC OXIDE; NITRITES; VASODILATION;

EID: 33646671928     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000204350.44226.9a     Document Type: Review

References (134)

1. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary-artery and vein possesses pharmacological and chemical-properties identical to those of nitric-oxide radical. Circ Res. 1987;61:866-879.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, ed. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium. New York: Raven Press; 1988.
4. Ignarro LJ, Byrns RE, Wood KS. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In: Vanhoutte PM, ed. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium. New York: Raven Press; 1988.
5. Lancaster JR. Simulation of the diffusion and reaction of endogenously produced nitric-oxide. Proc Natl Acad Sci U S A. 1994;91:8137-8141.
6. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth-muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric-oxide - evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
7. Klescev AL, Mordvincev PI, Vanin AF. Nitric-oxide and iron roles in hypotensive action of dinitrosyl iron complexes with various anion ligands. Studia Biophysica. 1985;105:93-102.
8. Bates JN, Harrison DG, Myers PR, Minor RL. Edrf - nitrosylated compound or authentic nitric-oxide. Basic Res Cardiol. 1991;86:17-26.
9. Vanin AF. Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands. FEBS Lett. 1991;289:1-3.
10. Mulsch A, Mordvintcev P, Vanin AF, Busse R. The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(Ii) complex is stored in a protein-bound form in vascular tissue and is released by thiols. FEBS Lett. 1991;294:252-256.
11. Vedernikov YP, Mordvintcev PI, Malenkova IV, Vanin AF. Similarity between the vasorelaxing activity of dinitrosyl iron cysteine complexes and endothelium-derived relaxing factor. Eur J Pharmacol. 1992;211:313-317.
12. Stamler JS, Jaraki O, Osborne J, Simon D, Keaney J, Vita J, Loscalzo J. S-nitroso-albumin is the predominant bioactive form of nitric-oxide in human plasma. Circulation. 1992;86:757.
13. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric-oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum-albumin. Proc Natl Acad Sci U S A. 1992;89:7674-7677.
14. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221-226.
15. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu XL, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9:1498-1505.
16. Nagababu E, Ramasamy S, Abernethy DR, Rifkind JM. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J Biol Chem. 2003;278:46349-46356.
17. 16a. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, Ognibene FP, Cannon RO. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A. 2000;97:11482-11487.
18. 16b. Modin A, Bjorne H, Herulf M, Alving K, Weitzberg E, Lundburg JON. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiologica Scandinavica. 2001;171:9-16.
19. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 1998;427:225-228.
20. Li HT, Samouilov A, Liu XP, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction - Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem. 2001;276:24482-24489.
21. Li HT, Samouilov A, Liu XP, Zweier JL. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem. 2004;279:16939-16946.
22. Zhang Z, Naughton D, Winyard PG, Benjamin N, Blake DR, Symons MCR. Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun. 1998;249:767-772.
23. Huang KT, Keszler A, Patel N, Patel RP, Gladwin MT, Kim-Shapiro DB, Hogg N. The reaction between nitrite and deoxyhemoglobin: reassment of reaction kinetics and stoichiometry. J Biol Chem. 2005;280:31126-31131.
24. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, A.Ringwood L, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, Gladwin MT. Enzymatic fnction of hemoglobin as a nitrite reductase that produces nitric oxide under allosteric control. J Clin Invest. 2005;115:2099-2107.
25. Duranski MR, Greer JJM, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang XD, Kevil CG, Gladwin MT, Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005;115:1232-1240.
26. Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Am Med Assoc. 2005;293:1477-1484.
27. Hunter CJ, Dejam A, Blood AB, Shields H, Kim-Shapiro D, Machado RF, Tarekegn S, Mulla N, Hopper AO, Schechter AN, Power GG, Gladwin MT. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med. 2004;10:1122-1127.
28. Doyle MP, Hoekstra JW. Oxidation of nitrogen-oxides by bound dioxygen in hemoproteins. J Inorg Biochem. 1981;14:351-358.
29. Eich RF, Li TS, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, Johnson KA, Smith RD, Phillips GN, Olson JS. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochem US. 1996;35:6976-6983.
30. Herold S, Exner M, Nauser T. Kinetic and mechanistic studies of the NO center dot-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry-US. 2001;40:3385-3395.
31. Lancaster JR. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide-Biol Ch. 1997;1:18-30.
32. Carlsen E, Comroe JH. The rate of uptake of carbon monoxide and of nitric oxide by normal and human erythrocytes and experimentally produced spherocytes. J Gen Physiol. 1958;42:83-107.
33. Coin JT, Olson JS. Rate of oxygen-uptake by human red blood-cells. J Biol Chem. 1979;254:1178-1190.
34. Butler AR, Megson IL, Wright PG. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta. 1998;1425:168-176.
35. Vaughn MW, Kuo L, Liao JC. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Physiol-Heart Circul Physiol. 1998;43:H2163-H2176.
36. Liao JC, Hein TW, Vaughn MW, Huang KT, Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A. 1999;96:8757-8761.
37. Vaughn MW, Huang KT, Kuo L, Liao JC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem. 2000;275:2342-2348.
38. Vaughn MW, Huang KT, Kuo L, Liao JC. Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide-Biol Ch. 2001;5:18-31.
39. Liu XP, Samouilov A, Lancaster JR, Zweier JL. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J Biol Chem. 2002;277:26194-26199.
40. Huang KT, Han TH, Hyduke DR, Vaughn MW, Van Herle H, Hein TW, Zhang CH, Kuo L, Liao JC. Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A. 2001;98:11771-11776.
41. Liu XP, Miller MJS, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem. 1998;273:18709-18713.
42. Azarov I, Huang KT, Basu S, Gladwin MT, Hogg N, Kim-Shapiro DB. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem. 2005;280:39024-38032.
43. Tsoukias NM, Kavdia M, Popel AS. A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation. Am J Physiol Heart Circul Physiol. 2004;286:H1043-H1056.
44. Tsai AG, Acero C, Nance PR, Cabrales P, Frangos JA, Buerk DG, Intaglietta M. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circul Physiol. 2005;288:H1730-H1739.
45. Li YSJ, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomechan. 2005;38:1949-1971.
46. Tsai AG, Cabrales P, Intaglietta M. Oxygen-carrying blood substitutes: a microvascular perspective. Expert Opin Biol Th. 2004;4:1147-1157.
47. Lehoux S, Tedgui A. Shear and signal transduction in the endothelial cell. Med Sci. 2004;20:551-556.
48. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol. 2003;285:C499-C508.
49. Hartridge H, Roughton FJW. The rate of distribution of gases between the red blood corpuscle and its fluid environment. Part I. Preliminary experiments on the rate of uptake of oxygen and carbon monoxide by sheep's corpuscles. J Physiol London. 1927;62:232-242.
50. Barry PH, Diamond JM. Effects of unstirred layers on membrane phenomena. Physiol Rev. 1984;64:763-872.
51. Han TH, Liao JC. Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim Biophys Acta. 2005;1723:135-142.
52. Tsoukias NM, Popel AS. Erythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin. Am J Physiol-Heart Circul Physiol. 2002;282:H2265-H2277.
53. Loscalzo J. Nitric oxide binding and the adverse effects of cell-free hemoglobins: what makes us different from earthworms. J Lab Clin Med. 1997;129:580-583.
54. Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E, Intaglietta M. Molecular dimensions of Hb-based O-2 carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circul Physiol 2000;279:H908-H915.
55. Matheson B, Kwansa HE, Bucci E, Rebel A, Koehler RC. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol. 2002;93:1479-1486.
56. Dull RO, DeWitt BJ, Dinavahi R, Schwartz L, Hubert C, Pace N, Fronticelli C. Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J Appl Physiol. 2004;97:1930-1937.
57. Lamkin-Kennard KA, Jaron D, Buerk DG. Impact of the Fahraeus effect on NO and O-2 biotransport: a computer model. Microcirculation. 2004;11:337-349.
58. Cassoly R, Gibson QH. Conformation, co-operativity and ligand-binding in human hemoglobin. J Mol Biol. 1975;91:301-313.
59. Morris RJ, Gibson QH. The role of diffusion in limiting the rate of ligand-binding to hemoglobin. J Biol Chem. 1980;255:8050-8053.
60. Huang Z, Hearne L, Irby CE, King SB, Ballas SK, Kim-Shapiro DB. Kinetics of increased deformability of deoxygenated sickle cells upon oxygenation. Biophys J. 2003;85:2374-2383.
61. Kim-Shapiro DB. Hemoglobin-nitric oxide cooperativity: Is NO the third respiratory ligand? Free Radic Biol Med. 2004;36:402-412.
62. Moore EG, Gibson QH. Cooperativity in dissociation of nitric-oxide from hemoglobin. J Biol Chem. 1976;251:2788-2794.
63. Sharma VS, Ranney HM. Dissociation of NO from Nitrosylhemoglobin. J Biol Chem. 1978;253:6467-6472.
64. Hille R, Olson JS, Palmer G. Spectral transitions of nitrosyl hemes during ligand-binding to hemoglobin. J Biol Chem. 1979;254:2110-2120.
65. Azizi F, Kielbasa JE, Adeyiga AM, Maree RD, Frazier M, Yakabu M, Shields H, King SB, Kim-Shapiro DB. Rates of nitric oxide dissociation from hemoglobin. Free Radic Biol Med. 2005;39:145-151.
66. Cannon RO, Schechter AN, Panza JA, Ognibene FP, Pease-Fye ME, Waclawiw MA, Shelhamer JH, Gladwin MT. Effects of inhaled oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest. 2001;108:279-287.
67. Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye ME, Shelhamer JH, Schechter AN. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A. 2000;97:9943-9948.
68. Rassaf T, Bryan NS, Kelm M, Feelisch M. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med. 2002;33:1590-1596.
69. Bryan NS, Rassaf T, Maloney RE, Rodriguez CM, Saijo F, Rodriguez JR, Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo. Proc Natl Acad Sci U S A. 2004;101:4308-4313.
70. Schopfer FJ, Baker PRS, Giles G, Chumley P, Batthyany C, Crawford J, Patel RP, Hogg N, Branchaud BP, Lancaster JR, Freeman BA. Fatty acid transduction of nitric oxide signaling - Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor. J Biol Chem. 2005;280:19289-19297.
71. Baker PRS, Schopfer FJ, Sweeney S, Freeman BA. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci U S A. 2004;101:11577-11582.
72. Lim DG, Sweeney S, Bloodsworth A, White CR, Chumley PH, Krishna NR, Schopfer F, O'Donnell VB, Eiserich JP, Freeman BA. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci U S A. 2002;99:15941-15946.
73. Bloodsworth A, O'Donnell VB, Freeman BA. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol. 2000;20:1707-1715.
74. Bryan NS, Fernandez BO, Bauer SM, Gauria-Saura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nature Chem Biol. 2005;1:290-297.
75. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, Ognibene FP, Cannon RO. Role of circulating nitrite and S-nitrosohemoglobin in regulating regional vascular flow in man. Circulation. 2000;102:172-173.
76. Lundberg JON, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric-oxide production in humans - measurements in expelled air. Gut. 1994;35:1543-1546.
77. Lundberg JO, Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol. 2005;25:915-922.
78. Reutov VP, Sorokina EG. NO-synthase and nitrite-reductase components of nitric oxide cycle. Biochem Moscow. 1998;63:874-884.
79. Moncada S, Palmer RMJ, Higgs EA. Nitric-oxide - physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
80. Ignarro LJ. Nitric Oxide Biology and Pathobiology. San Diego: Academic Press; 2000.
81. Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary nitrate on nitrite content of human saliva - possible relevance to in vivo formation of N-nitroso compounds. Food Cosmetics Toxicol. 1976;14:545-548.
82. Lundberg JO, Weitzberg E, Cole JA, Benjamin N. Opinion - nitrate, bacteria and human health. Nat Rev Microbiol. 2004;2:593-602.
83. Furchgott RF, Bhadrakom S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther. 1953;108:129-143.
84. Mittal CK, Arnold WP, Murad F. Characterization of protein inhibitors of guanylate cyclase activation from rat-heart and bovine lung. J Biol Chem. 1978;253:1266-1271.
85. Ignarro L, Gruetter C A. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochim. Biophys. Acta. 1980;631:221-231.
86. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric-oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
87. Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiss C, Strauer BE, Feelisch M, Kelm M. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest. 2002;109:1241-1248.
88. McMahon TJ. Hemoglobin and nitric oxide. N Engl J Med. 2003;349:403.
89. Pawloski JR. Hemoglobin and nitric oxide. N Engl J Med. 2003;349:403-404.
90. Tsikas D, Frolich JC. Is circulating nitrite a directly acting vasodilator? Clin Sci. 2002;103:107-108.
91. Stepuro II, Chaikovskaya NA, Solodunov AA, Artsukevich AN. Generation of NO during oxidation of hemoglobin ferroforms by nitrite. Biochem Moscow. 1997;62:960-966.
92. Kozlov AV, Staniek K, Nohl H. Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett. 1999;454:127-130.
93. Bjorne H, Petersson J, Phillipson M, Weltzberg E, Holm L, Lundberg JO. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J Clin Invest. 2004;113:106-114.
94. Dejam A, Hunter CJ, Pelletier MM, Hsu LL, Machado RF, Shiva S, Power GG, Kelm M, Gladwin MT, Schechter AN. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood. 2005;106:734-739.
95. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD Jr, Kraus D, Ho C, Gladwin MT, Patel RP. Hypoxia, red blood cells and nitrite regulate NO-dependent hypoxic vasodilatation. Blood. 2006;107:566-574.
96. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, Ognibene FP, Cannon RO. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A. 2000;97:11482-11487.
97. Tsuchiya K, Kanematsu Y, Yoshizumi M, Ohnishi H, Kirima K, Izawa Y, Shikishima M, Ishida T, Kondo S, Kagami S, Takiguchi Y, Tamaki T. Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circul Physiol. 2005;288:H2163-H2170.
98. Brooks J. The action of nitrite on haemoglobin in the absence of oxygen. Proc Royal Soc London B Biol Sci. 1937;123:368-382.
99. Doyle MP, Pickering RA, Deweert TM, Hoekstra JW, Pater D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem. 1981;256:2393-2398.
100. Luchsinger BP, Rich EN, Yan Y, Williams EM, Stamler JS, Singel DJ. Assessments of the chemistry and vasodilatory activity of nitrite with hemoglobin under physiologically relevant conditions. J Inorg Biochem. 2005;99:912-921.
101. Cooper CE. Nitric oxide and iron proteins. Biochim Biophys Acta Bioenerg. 1999;1411:290-309.
102. Jeffers A, Xu X, Huang KT, Cho M, Hogg N, Patel RP, Kim-Shapiro DB. Hemoglobin mediated nitrite activation of soluble guanylyl cyclase. Comp Biochem Physiol A Mol Integr Physiol. 2005;142:130-135.
103. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034-2037.
104. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998;391:169-173.
105. McMahon TJ, Stone AE, Bonaventura J, Singel DJ, Stamler JS. Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin. J Biol Chem. 2000;275:16738-16745.
106. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature. 2001;409:622-626.
107. McMahon TJ, Moon RE, Luschinger BP, Carraway MS, Stone AE, Stolp BW, Gow AJ, Pawloski JR, Watke P, Singel DJ, Piantadosi CA, Stamler JS. Nitric oxide in the human respiratory cycle. Nat Med. 2002;8:711-717.
108. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol. 2005;67:99-145.
109. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A. 1999;96:9027-9032.
110. Hobbs AJ, Gladwin MT, Patel RP, Williams DLH, Butler AR. Haemoglobin: NO transporter, NO inactivator or NOne of the above? Trends Pharmacol Sci. 2002;23:406-411.
111. Schechter AN, Gladwin MT. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med. 2003;348:1483-1485.
112. Gladwin MT, Lancaster JR, Freeman BA, Schechter AN. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat Med. 2003;9:496-500.
113. Gladwin MT, Schechter AN. NO contest - nitrite versus S-nitroso-hemoglobin. Circ Res. 2004;94:851-855.
114. Gow AJ. Nitric oxide, hemoglobin, and hypoxic vasodilation. Am J Respir Cell Mol Biol 2005;32:479-482.
115. Robinson JM, Lancaster JR. Hemoglobin-mediated, hypoxia-induced vasodilation via nitric oxide - mechanism(s) and physiologic versus pathophysiologic relevance. Am J Respir Cell Mol Biol. 2005;32:257-261.
116. Frehm EJ, Bonaventura J, Gow AJS. Nitrosohemoglobin: an allosteric mediator of NO group function in mammalian vasculature. Free Radic. Biol. Med. 2004;I37:442-453.
117. Gladwin MT, Wang XD, Reiter CD, Yang BK, Vivas EX, Bonaventura C, Schechter AN. S-nitrosohemoglobin is unstable in the reductive erythrocyte environment and lacks O-2/NO-linked allosteric function. J Biol Chem. 2002;277:27818-27828.
118. Rassaf T, Bryan NS, Maloney RE, Specian V, Kelm M, Kalyanaraman B, Rodriguez J, Feelisch M. NO adducts in mammalian red blood cells: too much or too little? Nat Med. 2003;9:481-482.
119. Piknova B, Gladwin MT, Schechter AN, Hogg N. Electron paramagenetic resonance analysis of nitrosylhemoglobin in humans during NO inhalation. J Biol Chem. 2005;280:40583-40588.
120. Huang Z, Louderback JG, Goyal M, Azizi F, King SB, Kim-Shapiro DB. Nitric oxide binding to oxygenated hemoglobin under physiological conditions. Biochim Biophys Acta. 2001;1568:252-260.
121. Han TH, Hyduke DR, Vaughn MW, Fukuto JM, Liao JC. Nitric oxide reaction with red blood cells and hemoglobin under heterogeneous conditions (vol 99, pg 7763, 2002). Proc Natl Acad Sci U S A. 2002;99:10227.
122. Huang Z, Ucer KB, Murphy T, Williams RT, King SB, Kim-Shapiro DB. Kinetics of nitric oxide binding to R-state hemoglobin. Biochem Biophys Res Commun. 2002;292:812-818.
123. Joshi MS, Ferguson TB, Han TH, Hyduke DR, Liao JC, Rassaf T, Bryan N, Feelisch M, Lancaster JR. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci U S A. 2002;99:10341-10346.
124. Zhang Y, Hogg N. Mixing artifacts from the bolus addition of nitric oxide to oxymyoglobin: Implications for S-nitrosothiol formation. Free Radic Biol Med. 2002;32:1212-1219.
125. Xu XL, Cho M, Spencer NY, Patel N, Huang Z, Shields H, King SB, Gladwin MT, Hogg N, Kim-Shapiro DB. Measurements of nitric oxide on the heme iron and beta-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation. Proc Natl Acad Sci U S A. 2003;100:11303-11308.
126. Huang KT, Azarov I, Basu S, Huang J, Kim-Shapiro DB. Lack of allosterically controlled intramolecular transfer of nitric oxide from the heme to cysteine in the beta subunit of hemoglobin 10.1182/blood-2005-10-4104. Blood. 2005:2005-2010-4104.
127. Crawford JH, White CR, Patel RP. Vasoactivity of S-nitrosohemoglobin: role of oxygen, heme, and NO oxidation states. Blood. 2003;101:4408-4415.
128. Reiter CD, Wang XD, Tanus-Santos JE, Hogg N, Cannon RO, Schechter AN, Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-1389.
129. Reiter CD, Gladwin MT. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol. 2003;10:99-107.
130. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin - a novel mechanism of human disease. JAMA. 2005;293:1653-1662.
131. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886-895.
132. Nolan VG, Wyszynski DF, Farrer LA, Steinberg MH. Hemolysis-associated priapism in sickle cell disease. Blood. 2005;106:3264-3267.
133. Minneci PC, Deans KJ, Huang Z, Yuen PST, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest. 2005;115:3409-3417.
134. Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A. 2004;101:13683-13688.